BioCentury
ARTICLE | Company News

BioChem deal

January 31, 2000 8:00 AM UTC

BCHE said it has agreed in principle to sell its diagnostics division, BioChem ImmunoSystems Inc. (Montreal), to a management-led group. A C$17 million (US$11.8 million) charge for the planned sale wa...